These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 27819521)
1. MicroRNA-326 sensitizes human glioblastoma cells to curcumin via the SHH/GLI1 signaling pathway. Yin S; Du W; Wang F; Han B; Cui Y; Yang D; Chen H; Liu D; Liu X; Zhai X; Jiang C Cancer Biol Ther; 2018 Apr; 19(4):260-270. PubMed ID: 27819521 [TBL] [Abstract][Full Text] [Related]
2. Curcumin suppresses malignant glioma cells growth and induces apoptosis by inhibition of SHH/GLI1 signaling pathway in vitro and vivo. Du WZ; Feng Y; Wang XF; Piao XY; Cui YQ; Chen LC; Lei XH; Sun X; Liu X; Wang HB; Li XF; Yang DB; Sun Y; Zhao ZF; Jiang T; Li YL; Jiang CL CNS Neurosci Ther; 2013 Dec; 19(12):926-36. PubMed ID: 24165291 [TBL] [Abstract][Full Text] [Related]
3. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins. Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373 [TBL] [Abstract][Full Text] [Related]
4. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200. Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671 [TBL] [Abstract][Full Text] [Related]
5. Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma. Wu H; Liu Q; Cai T; Chen YD; Wang ZF Mol Med Rep; 2015 Oct; 12(4):5461-6. PubMed ID: 26239619 [TBL] [Abstract][Full Text] [Related]
6. HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH/Gli1 signaling pathway. Yang W; Liu Y; Gao R; Yu H; Sun T Cancer Lett; 2018 Feb; 415():164-176. PubMed ID: 29222038 [TBL] [Abstract][Full Text] [Related]
7. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. Dhandapani KM; Mahesh VB; Brann DW J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214 [TBL] [Abstract][Full Text] [Related]
8. Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation. Liu YJ; Ma YC; Zhang WJ; Yang ZZ; Liang DS; Wu ZF; Qi XR Oncotarget; 2017 Jun; 8(26):42495-42509. PubMed ID: 28477008 [TBL] [Abstract][Full Text] [Related]
9. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy. Kundu P; Mohanty C; Sahoo SK Acta Biomater; 2012 Jul; 8(7):2670-87. PubMed ID: 22484149 [TBL] [Abstract][Full Text] [Related]
10. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas. Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108 [TBL] [Abstract][Full Text] [Related]
11. Curcumin suppresses glioblastoma cell proliferation by p-AKT/mTOR pathway and increases the PTEN expression. Wang Z; Liu F; Liao W; Yu L; Hu Z; Li M; Xia H Arch Biochem Biophys; 2020 Aug; 689():108412. PubMed ID: 32445778 [TBL] [Abstract][Full Text] [Related]
12. Curcumin analogue BDDD-721 exhibits more potent anticancer effects than curcumin on medulloblastoma by targeting Shh/Gli1 signaling pathway. Gong W; Zhao W; Liu G; Shi L; Zhao X Aging (Albany NY); 2022 Jul; 14(13):5464-5477. PubMed ID: 35802536 [TBL] [Abstract][Full Text] [Related]
13. Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy. Ming J; Sun B; Li Z; Lin L; Meng X; Han B; Wang R; Wu P; Li J; Cai J; Jiang C Aging (Albany NY); 2017 Apr; 9(4):1233-1247. PubMed ID: 28446712 [TBL] [Abstract][Full Text] [Related]
14. Gli1 is a potential target for alleviating multidrug resistance of gliomas. Cui D; Xu Q; Wang K; Che X J Neurol Sci; 2010 Jan; 288(1-2):156-66. PubMed ID: 19818966 [TBL] [Abstract][Full Text] [Related]
15. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Schreck KC; Taylor P; Marchionni L; Gopalakrishnan V; Bar EE; Gaiano N; Eberhart CG Clin Cancer Res; 2010 Dec; 16(24):6060-70. PubMed ID: 21169257 [TBL] [Abstract][Full Text] [Related]
16. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway. Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920 [TBL] [Abstract][Full Text] [Related]
17. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway. Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865 [TBL] [Abstract][Full Text] [Related]
18. Essential role of Gli proteins in glioblastoma multiforme. Santoni M; Burattini L; Nabissi M; Morelli MB; Berardi R; Santoni G; Cascinu S Curr Protein Pept Sci; 2013 Mar; 14(2):133-40. PubMed ID: 23544423 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma. Shang C; Tang W; Pan C; Hu X; Hong Y Cancer Chemother Pharmacol; 2018 Apr; 81(4):671-678. PubMed ID: 29397407 [TBL] [Abstract][Full Text] [Related]